A study for safety of excessive intake of supplements Open-label study - A study for safety of excessive intake of supplements

Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 15 人开始时间: 2021年3月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Persons with a history of liver disease, renal disease, digestive system disease, heart disease, diabetes, or other diseases that may affect the results of this study, or subjects with a history of surgery (2) Subjects with abnormal liver function and renal function test values (3) Subjects with diseases currently being treated (4) Subjects with food and drug allergies (5) Subjects with anemia symptoms (6) Subjects who play intense sports and subjects who are on a diet (7) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (8) Subjects who are continuously treated with medicines (including OTC and prescription drugs) (9) Subjects who are excessively ingesting alcohol (10) Subjects who cannot stop drinking from the day before the test to the day of the test (11) Pregnant subjects or subjects who are planning to become pregnant or breastfeed during the test period (12) Subjects who are participating in or will participate in other clinical trials at the start of this study. (13) Other subjects judged by the investigator to be inappropriate

发起方

Miura Clinic, Medical Corporation Kanonkai